# Lumos Diagnostics signs exclusive U.S. distribution deal with PHASE Scientific for FebriDx

Lumos Diagnostics has signed a six-year exclusive U.S. distribution agreement with PHASE Scientific for FebriDx, with $2.0 million upfront and potential total contract value of up to $317 million.

- Type: Contract
- Announced: 2025-07-16
- Where: United States
- Value: $2.00M
- Status: announced
- Products: FebriDx diagnostic test
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Lumos Diagnostics](https://endata.com/companies/59809.md)
- [PHASE Scientific](https://endata.com/companies/86064.md) (customer)

## Sources

- [lumosdiagnostics.com](https://lumosdiagnostics.com/news-item/lumos-diagnostics-signs-exclusive-us-distribution-and-supply-agreement-with-phase-scientific-for-febridx), 2025-07-16: "This distribution agreement reflects a pivotal moment in Lumos’ evolution."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.